File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The evolving role of radiation therapy as treatment for liver metastases

TitleThe evolving role of radiation therapy as treatment for liver metastases
Authors
Alrabiah, KhalidLiao, GuixiangShen, QiChiang, Chi LeungDawson, Laura A
KeywordsLiver Local Treatment
Liver metastases
Local control
Overall survival
Stereotactic body radiotherapy
Toxicity
Issue Date19-Jul-2022
PublisherElsevier
Citation
Journal of the National Cancer Center, 2022, v. 2, n. 3, p. 183-187 How to Cite?
DOI: http://dx.doi.org/10.1016/j.jncc.2022.06.004
AbstractLiver metastases occur commonly in many solid malignancies. With advances in systemic therapies and increased life expectancy, the role of using local therapies in oligo-metastases is rapidly increasing. Stereotactic body radiotherapy (SBRT) is an emerging precision therapy that is being used more frequently in the treatment for unresectable liver metastases. This review focuses on the role of SBRT for liver metastases, principles of treatment, clinical outcomes, toxicity, and optimal patient selection.
Persistent Identifierhttp://hdl.handle.net/10722/344928
ISSN
2667-0054
2023 Impact Factor: 7.6
2023 SCImago Journal Rankings: 2.928
ISI Accession Number ID
WOS:001103421700002

 

DC FieldValueLanguage
dc.contributor.authorAlrabiah, Khalid-
dc.contributor.authorLiao, Guixiang-
dc.contributor.authorShen, Qi-
dc.contributor.authorChiang, Chi Leung-
dc.contributor.authorDawson, Laura A-
dc.date.accessioned2024-08-14T08:56:18Z-
dc.date.available2024-08-14T08:56:18Z-
dc.date.issued2022-07-19-
dc.identifier.citationJournal of the National Cancer Center, 2022, v. 2, n. 3, p. 183-187-
dc.identifier.issn2667-0054-
dc.identifier.urihttp://hdl.handle.net/10722/344928-
dc.description.abstractLiver metastases occur commonly in many solid malignancies. With advances in systemic therapies and increased life expectancy, the role of using local therapies in oligo-metastases is rapidly increasing. Stereotactic body radiotherapy (SBRT) is an emerging precision therapy that is being used more frequently in the treatment for unresectable liver metastases. This review focuses on the role of SBRT for liver metastases, principles of treatment, clinical outcomes, toxicity, and optimal patient selection.-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofJournal of the National Cancer Center-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectLiver Local Treatment-
dc.subjectLiver metastases-
dc.subjectLocal control-
dc.subjectOverall survival-
dc.subjectStereotactic body radiotherapy-
dc.subjectToxicity-
dc.titleThe evolving role of radiation therapy as treatment for liver metastases-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.jncc.2022.06.004-
dc.identifier.scopuseid_2-s2.0-85134825713-
dc.identifier.volume2-
dc.identifier.issue3-
dc.identifier.spage183-
dc.identifier.epage187-
dc.identifier.isiWOS:001103421700002-
dc.identifier.issnl2667-0054-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats